BRF1 and hepatocellular carcinoma: Given that high expression of Brf1 is associated with short overall survival times (Figure 2 and Supplementary Figure S1), reducing the cellular level of Brf1 of HCC patients may be used to extend overall survival period and measuring the level of Brf1 expression may be used to monitor the efficacy of treatment of HCC.